BiotechPresident's meeting room丨How to integrate Biotech with traditional pharmaceutical companies?

With the release of policy dividends, the return of returnees and the influx of large amounts of capital, China's drug innovation and development is ushering in a period of acceleration, which can be said to be mass innovation. However, the homogenization

2021-06-22